skip to content

2024 Cannabis Virtual Continuing Education Sessions

July 18, 2024

2024 Cannabis Virtual Continuing Education Sessions

A satellite to the joint conference of the DeGroote Centre and Research Society on Marijuana

Thursday, July 18th, 2024

[All virtual sessions are live but may be streamed for 30-days following the event.]


These sessions are for healthcare providers to have access to the most current research and guidance regarding the use of medical cannabis and cannabis use in general. This one-credit-per-hour Group- Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the McMaster University Continuing Professional Development Program for up to 4.0 Mainpro+ credits. In addition, the curriculum has been accredited for four CE hours by the Ontario Psychological Association.


Session #1

9:00 am – 10:00 am

Cannabis and Cannabinoid Fundamentals

Presenter: Dr. James MacKillop

This session will introduce learners to cannabis as medicine and estimate the scope of recreational and medical cannabis use in Canada.


Session #2

11:00 am – 12:00 pm

State of the Evidence on Medical Cannabis

Presenter: Dr. Jason Busse

This session will allow learners to describe and critically appraise the moderate to high certainty evidence of cannabis use for various medical conditions.


Session #3

1:00 pm – 2:00 pm

Risks and Harms from Cannabis

Presenter: Dr. James MacKillop

This session will explain the evidence to inform both short and long-term harms associated with use of medical cannabis – including overall prevalence, psychiatric events, dependence and withdrawal syndrome, and serious events leading to discontinuation.


Session #4

3:00 pm – 4:00 pm

Practical Considerations for Treating Chronic Pain with Medical Cannabis

Presenters: Dr. Ramesh Zacharias and Dr. Mahmoud Siyam

This session will describe the practical applications of cannabis for medical purposes with specific examples drawn from the area of chronic pain, including an examination of drug interactions.


Click here for more information